IBB vs IXJ: holdings overlap, shared companies and scores
As of September 11, 2026, IBB and IXJ overlap 10.8% by weight. iShares Biotechnology ETF (IBB): U.S. biotechnology stocks. iShares Global Healthcare ETF (IXJ): Global healthcare sector stocks.
Updated September 11, 2026
How much do IBB and IXJ overlap?
As of September 11, 2026, IBB and IXJ overlap 10.8% by weight.
44% of IBB is already inside IXJ.
11% of IXJ is already inside IBB.
IBB holds 239 companies and IXJ holds 121; 13 are in both.
Computed by ETF Copilot from both funds' holdings rather than quoted from a data provider, and rebuilt nightly.
How does ETF Copilot score IBB and IXJ?
As of September 11, 2026, ETF Copilot scores IBB 3.1 out of 10 and IXJ 5.4 out of 10.
They differ most on Growth: IBB 1.9 and IXJ 6.8.
The five factor scores behind them are set out below, 0–10 and higher is better, ranked against every US equity ETF we track.
| Factor | IBB | IXJ |
|---|---|---|
| Growth | 1.9 | 6.8 |
| Valuation | 3.5 | 5.9 |
| Risk | 4.2 | 7.2 |
| Quality | 3.4 | 5.7 |
| Return | 3.1 | 2.2 |
IXJ is the cheaper of the two at 0.38% a year
As of September 11, 2026, IBB charges 0.44% a year, yields 0.46% and holds $10.7B in assets across 239 positions.
As of September 11, 2026, IXJ charges 0.38% a year, yields 1.81% and holds $4.3B in assets across 121 positions.
| Measure | IBB | IXJ |
|---|---|---|
| Expense ratio | 0.44% | 0.38% |
| Dividend yield | 0.46% | 1.81% |
| Assets under management | $10.7B | $4.3B |
| Holdings | 239 | 121 |
Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.
Where IBB and IXJ trade against their own history
IBB trades at 22.7 times earnings, against its own median of 21.5, and is more expensive than 60% of its own 114 monthly readings since 2017.
IXJ trades at 26.5 times earnings, against its own median of 24.1, and is more expensive than 81% of its own 114 monthly readings since 2017.
What moved IBB and IXJ this week
IBB fell 5.1% in the week to September 11, 2026. The holdings that moved it most were Amgen (−15.0%), Vertex Pharmaceuticals (−7.6%) and Regeneron Pharmaceuticals (−7.3%); Roivant Sciences (+18.6%) pushed the other way.
IXJ fell 5.0% in the week to September 11, 2026. The holdings that moved it most were Novartis (−15.2%), Amgen (−15.0%) and Eli Lilly (−3.8%); HCA Healthcare (+4.3%) pushed the other way.
What do IBB and IXJ each hold?
What's inside IBB: AI 1%.
48% of IBB is its ten largest holdings.
What's inside IXJ: AI 0%.
46% of IXJ is its ten largest holdings.
Compare with similar funds
Cite this
ETF Copilot, “IBB vs IXJ holdings overlap and scores”, as of September 11, 2026.
https://etf-copilot.com/compare/ibb-vs-ixj
Register free to unlock IBB vs IXJ prices and holdings on ETF Copilot.
Register free →